Roiled by C-suite tur­moil and a CRL, Im­munomedics salutes CMO Rob Ian­none as he makes a quick ex­it

Just days af­ter cel­e­brat­ing his first an­niver­sary as chief med­ical of­fi­cer at Im­munomedics $IM­MU, I/O vet Rob Ian­none is hit­ting the ex­it door. 

In a state­ment out this morn­ing, Ian­none said he was mak­ing an­oth­er ca­reer leap to Penn­syl­va­nia, go­ing where he could be close to his fam­i­ly “af­ter many years of hav­ing worked far away from home.” The can­cer R&D vet, who jumped to Im­munomedics af­ter a stint at As­traZeneca, didn’t men­tion ex­act­ly where he’s head­ed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.